ATE44235T1 - Verwendung von kupfer und fettsaeulen. - Google Patents

Verwendung von kupfer und fettsaeulen.

Info

Publication number: ATE44235T1
Authority: AT; Austria
Prior art keywords: copper; gamma; linolenic acid; acids; calculated
Prior art date: 1984-10-03

Application number

AT85306551T

Other languages

English (en)

Inventor

David Frederick C O E Horrobin

Stephen C Efamol Resea Cunnane

Valley Ind Mall Anna Annapolis

Mehar Singh C O Efamol R Manku

Original Assignee

Efamol Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-03

Filing date

1985-09-16

Publication date

1989-07-15

1985-09-16 Application filed by Efamol Ltd filed Critical Efamol Ltd

1989-07-15 Application granted granted Critical

1989-07-15 Publication of ATE44235T1 publication Critical patent/ATE44235T1/de

Links

239000005749 Copper compound Substances 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 2
150000007513 acids Chemical class 0.000 abstract 2
150000001880 copper compounds Chemical class 0.000 abstract 2
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 2
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 2
229960002733 gamolenic acid Drugs 0.000 abstract 2
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
229910052802 copper Inorganic materials 0.000 abstract 1
239000010949 copper Substances 0.000 abstract 1
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Cardiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT85306551T 1984-10-03 1985-09-16 Verwendung von kupfer und fettsaeulen. ATE44235T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB848425006A GB8425006D0 (en)	1984-10-03	1984-10-03	Composition of copper/fatty acids
EP85306551A EP0181689B1 (de)	1984-10-03	1985-09-16	Verwendung von Kupfer und Fettsäulen

Publications (1)

Publication Number	Publication Date
ATE44235T1 true ATE44235T1 (de)	1989-07-15

Family

ID=10567647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85306551T ATE44235T1 (de)	1984-10-03	1985-09-16	Verwendung von kupfer und fettsaeulen.

Country Status (10)

Country	Link
US (1)	US4965075A (de)
EP (1)	EP0181689B1 (de)
JP (1)	JPS61171419A (de)
AT (1)	ATE44235T1 (de)
AU (1)	AU581252B2 (de)
CA (1)	CA1268116A (de)
DE (1)	DE3571200D1 (de)
GB (1)	GB8425006D0 (de)
IE (1)	IE58492B1 (de)
ZA (1)	ZA857182B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8516906D0 (en) *	1985-07-04	1985-08-07	Efamol Ltd	Pharmaceutical & dietary composition
GB8524276D0 (en) *	1985-10-02	1985-11-06	Efamol Ltd	Pharmaceutical & dietary compositions
GB8621816D0 (en) *	1986-09-10	1986-10-15	Efamol Ltd	Therapeutic composition
US5599840A (en) *	1986-11-26	1997-02-04	Bar Ilan University	Physiologically active and nutritional composition
US4851431A (en) *	1986-11-26	1989-07-25	Bar Ilan University	Physiologically active and nutritional composition
GB8715914D0 (en) *	1987-07-07	1987-08-12	Efamol Ltd	Treatment of cerabral disorders
US5034415A (en) *	1987-08-07	1991-07-23	Century Laboratories, Inc.	Treatment of diabetes mellitus
JP2716739B2 (ja) *	1988-07-26	1998-02-18	インデナエス．ピー．エイ	血管運動作用を有する化粧用組成物
IL91802A (en) *	1988-10-27	1994-05-30	Univ Bar Ilan	Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
US5411748A (en) *	1992-10-22	1995-05-02	Song Moon K	Prostate extract supplemented with zinc
WO1994015464A1 (en) *	1993-01-15	1994-07-21	Abbott Laboratories	Structured lipids
DE69326075T2 (de) *	1993-12-31	1999-12-23	Rijksuniversiteit Limburg, Maastricht	Verwendung von Zusammensetzungen essentieller Fettsäuren
US7138431B1 (en) *	1998-02-23	2006-11-21	Wake Forest University	Dietary control of arachidonic acid metabolism
US6107334A (en) *	1998-02-23	2000-08-22	Wake Forest University	Dietary control of arachidonic acid metabolism
US6548540B2 (en) *	1998-09-08	2003-04-15	Charlotte-Mecklenburg Hospital Authority	Method of treating cancer using dithiocarbamate derivatives
CA2436650A1 (en) *	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
RU2714323C2 (ru)	2014-06-04	2020-02-14	ДиЭс БАЙОФАРМА ЛИМИТЕД	Фармацевтические композиции, содержащие дглк, и их применение
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1082624A (en) *	1965-02-26	1967-09-06	Calmic Ltd	Improvements in or relating to therapeutically active compounds
GB1240513A (en) *	1968-09-13	1971-07-28	Ono Pharmaceutical Co	Poly-unsaturated fatty acid ester composition and its preparation
US4237118A (en) *	1972-03-06	1980-12-02	Howard Alan N	Dietary supplement and dietary methods employing said supplement for the treatment of obesity
GB1446431A (en) *	1972-04-20	1976-08-18	Williams J	Nutritional supplement
US3953591A (en) *	1974-04-29	1976-04-27	The Procter & Gamble Company	Fatty acid, polysiloxane and water-soluble polymer containing skin conditioning emulsion
CH621048A5 (de) *	1977-04-27	1981-01-15	Nestle Sa
DE2861560D1 (en) *	1977-11-28	1982-03-04	Barry Boettcher	Complexes of bivalent copper, methods of preparation thereof and compositions containing said complexes
IE47777B1 (en) *	1978-01-23	1984-06-13	Efamol Ltd	Pharmaceutical and dietary composition comprising gamma-linolenic acids
AU520987B2 (en) *	1978-05-08	1982-03-11	Victor Alexander Garten	Anti-arthritic preparation
FR2514643B1 (fr) *	1981-10-20	1986-07-04	Oreal	Lanolate de cuivre et compositions cosmetiques anti-acneiques le contenant
ATE24266T1 (de) *	1982-04-16	1987-01-15	Nestle Sa	Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
EP0106571A3 (de) *	1982-09-22	1984-07-25	Sentrachem Limited	Prophylaktische Substanz oder Komposition
GB8317248D0 (en) *	1983-06-24	1983-07-27	Wyeth John & Brother Ltd	Fat compositions

1984
- 1984-10-03 GB GB848425006A patent/GB8425006D0/en active Pending
1985
- 1985-09-16 AT AT85306551T patent/ATE44235T1/de not_active IP Right Cessation
- 1985-09-16 DE DE8585306551T patent/DE3571200D1/de not_active Expired
- 1985-09-16 EP EP85306551A patent/EP0181689B1/de not_active Expired
- 1985-09-19 ZA ZA857182A patent/ZA857182B/xx unknown
- 1985-09-19 IE IE231785A patent/IE58492B1/en not_active IP Right Cessation
- 1985-09-30 AU AU47998/85A patent/AU581252B2/en not_active Ceased
- 1985-10-02 JP JP60218175A patent/JPS61171419A/ja active Pending
- 1985-10-02 CA CA000492096A patent/CA1268116A/en not_active Expired - Fee Related
1988
- 1988-11-21 US US07/273,680 patent/US4965075A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU581252B2 (en)	1989-02-16
IE58492B1 (en)	1993-09-22
GB8425006D0 (en)	1984-11-07
ZA857182B (en)	1986-05-28
US4965075A (en)	1990-10-23
EP0181689B1 (de)	1989-06-28
JPS61171419A (ja)	1986-08-02
EP0181689A1 (de)	1986-05-21
DE3571200D1 (en)	1989-08-03
AU4799885A (en)	1986-04-10
IE852317L (en)	1986-04-03
CA1268116A (en)	1990-04-24

Legal Events

Date	Code	Title	Description
1989-11-15	UEP	Publication of translation of european patent specification
1999-06-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE44235T1 (de)	1989-07-15	Verwendung von kupfer und fettsaeulen.
EP0222483A3 (en)	1989-08-16	Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
AU562938B2 (en)	1987-06-25	7, 10, 13, 16 docosatetraenoic acid composition
GR3006068T3 (de)	1993-06-21
FR2564863B1 (fr)	1987-01-16	Procede d'elaboration d'un alliage ferreux a haute teneur en manganese par fusion reductrice.
EP0150709A3 (de)	1985-10-02	7-Oxabicycloheptan-Prostaglandin-Analoge
EP0087865A3 (en)	1984-03-07	Pharmaceutical composition
AU7018187A (en)	1987-09-24	Iron - containing composition and method for treatment of cancer
DE3485337D1 (de)	1992-01-23	Topische zubereitungen mit gehalt an teer und fettsaeuren.
EP0201159A3 (en)	1989-08-09	Pharmaceutical and dietary compositions containing linolenic acids for the treatment of benign prostatic hypertrophy
EP0218970A3 (en)	1989-10-25	Chiral rhodium-diphosphine complexes for asymmetrical hydrogenation
HUT45035A (en)	1988-05-30	Process for producing thiazolone derivatives
SE8800988D0 (sv)	1988-03-18	Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
AU570552B2 (en)	1988-03-17	1,4-dihydropyridine-3-carboxylates and salts thereof
AU1145583A (en)	1983-09-08	Composition containing an essential fatty acid and brotin
NO891679D0 (no)	1989-04-24	Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarbonsyreestere.
IL89142A0 (en)	1989-09-10	Method for the sequential oxidation of substituted-8-hydroxyquinolines to produce substituted-pyridine-2,3-dicarboxylic acids
KR960015807B1 (en)	1996-11-21	Process for the preparation of purified bis(2-hydrozyethyl) ester of 2,60naphthalenedi carboxylic acid
IE792328L (en)	1980-06-08	Derivatives of dihydropyrrole and tetrahydropyridine.
PT83192B (en)	1988-09-22	Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives
BG52067B2 (en)	1996-04-30	Antihypoxic and brain-protection antidote composition
CU21573A1 (en)	1987-07-22	Utilization of ii pyrido (2,1-b)-quinazolin ii one and derivatives, as inhibitor of the acid corrosion
ATE46338T1 (de)	1989-09-15	Verfahren zur herstellung von 3-cephem-4 carboxylsaeure-derivaten, substituiert in position 3.
JPS52156855A (en)	1977-12-27	Preparation of tetrahydro-t-oxo-2-furanacetic acid
NO166078C (no)	1991-05-29	Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituerte fenoksyprostatriensyrederivater.